This education will provide an overview and differentiation of currently available GLP-1 RAs to manage this disease, including mechanism of action, dosing optimization and administration, glycemic and extra-glycemic effects, safety and tolerability concerns, and early place in therapy according to treatment guidelines.
Complete the evaluation for CME/CE credit, click here:
surveys.francefoundation.com/...
For more accreditation information, visit:
www.francefoundation.com/9285...
This educational activity is intended for HCPs who care for patients with T2D, including primary care providers (MD/DOs), including those who specialize in family practice, as well as advanced practice professionals (nurse practitioners and PAs).
This activity is supported by an independent medical educational grant from Novo Nordisk.